Lv41
490 积分 2023-10-28 加入
Combining CD40 agonist mitazalimab with mFOLFIRINOX in previously untreated metastatic pancreatic ductal adenocarcinoma (OPTIMIZE-1): a single-arm, multicentre phase 1b/2 study
25天前
已完结
GATA6 Expression Distinguishes Classical and Basal-like Subtypes in Advanced Pancreatic Cancer
30天前
已完结
Updates in Molecular Profiling of Pancreatic Ductal Adenocarcinoma
30天前
已完结
Nab-paclitaxel plus S-1 versus nab-paclitaxel plus gemcitabine as first-line chemotherapy in patients with advanced pancreatic ductal adenocarcinoma: a randomized study
1个月前
已完结
First-line serplulimab in metastatic colorectal cancer: Phase 2 results of a randomized, double-blind, phase 2/3 trial
2个月前
已完结
Frontiers in radiopharmaceuticals for neuroendocrine tumors
3个月前
已完结
Imaging with [89Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumours of the lung and prostate: a phase 1/2, first-in-human trial
4个月前
已完结
Management of high-grade neuroendocrine neoplasms: impact of functional imaging
4个月前
已关闭
Functional heterogeneity of fibroblasts in primary tumors and metastases
5个月前
已完结
The heterogeneity of neutrophils in cancer and its implication for therapeutic targeting
6个月前
已完结
皖公网安备34019202002308
